Skip to main content
Oncoimmunology logoLink to Oncoimmunology
. 2019 Feb 27;8(5):e1584435. doi: 10.1080/2162402X.2019.1584435

Correction

PMCID: PMC6492966  PMID: 31069146

Article title: M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine

Authors: Karin M Knudson, Kristin C Hicks, Xiaoling Luo, Jin-Qiu Chen, Jeffrey Schlom, and Sofia R Gameiro

Journal: OncoImmunology

Bibliometrics: Volume 07, Number 05, pages e1426519 (14 pages)

DOI: http://doi.org/10.1080/2162402X.2018.1426519

When the article was published online, there were errors introduced in X-axis of graphs in Figures 1A, 1C, 1D, and Supplemental Figure S1A, which can be accessed on the publisher’s website. Instead of ‘nM’, it was processed as ‘μM’. Now the correct image has been processed. The authors apologize for the error.

Figure 1.

Figure 1.

M7824 binds to murine PD-L1 and suppresses murine TGFβ signaling.


Articles from Oncoimmunology are provided here courtesy of Taylor & Francis

RESOURCES